Keynote Speakers | 6th International Caparica Conference in Antibiotic Resistance 2024

Kenneth Burch, PhD

Boston College (USA)

A Platform for Personalized Medicine and Epidemiology

Elena Gómez-Sanz, PhD

University Hospital of Basel (Switzerland)

Elizabeth Grohmann, PhD

Berlin University of Applied Sciences (Germany)

Horizontal antimicrobial resistance transfer mechanisms in biofilms

Robert Bonomo, PhD

Case Western Reserve University (USA)

Rachel Powers, PhD

Grand Valley State University (USA)

Structural insights on β-lactamase mediated resistance in A. baumannii

Bruno Gonzalez-Zorn, PhD

University Complutense of Madrid (Spain)

Ganjun Yuan, PhD

College of Bioscience and Bioengineering, Jiangxi Agricultural University (China)

Drug combinations to prevent antimicrobial resistance: theory, scheme and practice

Tomasz Jarzembowski, PhD

Medical University of Gdánsk, Gdánsk (Poland)

Unexpected results of non antimicrobial pharmacotherapy: changes of bacterial resistance to beta-lactams

Ivan Rychlik, PhD

Veterinary Research Institute, Brno (Czech Republic)

Probiotics as an alternative to antibiotics: Lessons taken from chicken – microbiota interactions

Latania Logan, PhD

Emory University School of Medicine (USA)

Tackling the AR Conundrum: The role of community reservoirs in the spread of antibiotic resistance among children and healthy populations

Mara di Giulio, PhD

University of “G. d’Annunzio” Chieti-Pescara (Italy)

New strategies to tackle the antimicrobial resistance/tolerance in Helicobacter pylori infection

Yvonne Agersø, PhD

Novonesis; Copenhagen University (Denmark)

Intrinsic tetracycline resistance tet(L) sub-classes in Bacillus subtilis group species differ from the plasmid associated tet(L) found widespread in Gram-positive species

Melissa Brown, PhD

Flinders University (Australia)

QacA-mediated biocide resistance in staphylococci

Mayland Chang, PhD

University of Notre Dame (USA)

Oxadiazoles as Narrow-Spectrum Antibacterials and Spore Germination Inhibitors for Treatment of Clostridioides difficile Infection

Andrei Osterman, PhD

Sanford Burnham Prebys Medical Institute (USA)

Comparative resistomics of Acinetobacter baumannii

Yuk Sham, PhD

University of Minnesota (USA)

1-Hydroxypyridine-2(1H)-thione-6-carboxylic Acid as a potent metallo-β-lactamase inhibitor for rescuing β-lactam antibiotic therapy antibiotic activity in-vitro and in-vivo

Anthony Schryvers, PhD

University of Calgary (Canada)

Targeting metal ion acquisition in antibiotic resistant bacteria from an evolutionary perspective: lessons learned from Acinetobacter baumannii

Patrick Loll, PhD

Drexel University College of Medicine (USA)

The VanS sensor histidine kinase from type-B VRE recognizes vancomycin directly

Thilo Köhler, PhD

University of Geneva (Switzerland)

Personalized aerosolised bacteriophage treatment of a chronic lung infection due to multidrug-resistant Pseudomonas aeruginosa

Luís Pacheco, PhD

Federal University of Bahia (Brazil)

Whole-Genome Based Prediction of Phenotypic Antimicrobial Resistance Profiles in Multidrug-Resistant Pathogens

XXX, PhD

Affiliation: